Austar Lifesciences Limited (6118.HK)

HKD 0.79

(0.0%)

Revenue Summary of Austar Lifesciences Limited

Austar Lifesciences Limited's latest annual revenue in 2023 was 1.76 Billion CNY , down -20.86% from previous year.
Austar Lifesciences Limited's latest quarterly revenue in 2024 Q2 was 700.91 Million CNY , down 0.0% from previous quarter.
Austar Lifesciences Limited reported a annual revenue of 2.22 Billion CNY in annual revenue 2022, up 10.6% from previous year.
Austar Lifesciences Limited reported a annual revenue of 2.01 Billion CNY in annual revenue 2021, up 55.48% from previous year.
Austar Lifesciences Limited reported a quarterly revenue of 1.76 Billion CNY for 2023 FY, down -20.86% from previous quarter.
Austar Lifesciences Limited reported a quarterly revenue of 919.45 Million CNY for 2023 Q2, down -18.25% from previous quarter.

Annual Revenue Chart of Austar Lifesciences Limited (2023 - 2013)

Historical Annual Revenue of Austar Lifesciences Limited (2023 - 2013)

Year	Revenue	Revenue Growth
2023	1.76 Billion CNY	-20.86%
2022	2.22 Billion CNY	10.6%
2021	2.01 Billion CNY	55.48%
2020	1.29 Billion CNY	23.54%
2019	1.04 Billion CNY	28.46%
2018	816.58 Million CNY	49.3%
2017	546.93 Million CNY	-18.68%
2016	672.54 Million CNY	7.17%
2015	627.54 Million CNY	-7.68%
2014	679.75 Million CNY	-3.6%
2013	705.15 Million CNY	0.0%

Year	Revenue	Revenue Growth
2024 Q2	700.91 Million CNY	0.0%
2023 FY	1.76 Billion CNY	-20.86%
2023 Q2	919.45 Million CNY	-18.25%
2022 Q2	1.1 Billion CNY	-4.8%
2022 Q4	1.12 Billion CNY	1.87%
2022 FY	2.22 Billion CNY	10.6%
2021 Q2	855.37 Million CNY	9.95%
2021 FY	2.01 Billion CNY	55.48%
2021 Q4	1.15 Billion CNY	35.57%
2020 Q4	777.99 Million CNY	50.2%
2020 Q2	517.98 Million CNY	-9.32%
2020 FY	1.29 Billion CNY	23.54%
2019 Q2	477.78 Million CNY	-2.12%
2019 FY	1.04 Billion CNY	28.46%
2019 Q4	571.23 Million CNY	19.56%
2018 Q2	328.47 Million CNY	8.74%
2018 Q4	488.11 Million CNY	48.6%
2018 FY	816.58 Million CNY	49.3%
2017 FY	546.93 Million CNY	-18.68%
2017 Q4	302.08 Million CNY	23.37%
2017 Q2	244.85 Million CNY	-36.02%
2016 FY	672.54 Million CNY	7.17%
2016 Q2	289.83 Million CNY	-13.34%
2016 Q4	382.7 Million CNY	32.04%
2015 FY	627.54 Million CNY	-7.68%
2015 Q4	334.45 Million CNY	14.12%
2015 Q2	293.08 Million CNY	-18.34%
2014 FY	679.75 Million CNY	-3.6%
2014 Q4	358.92 Million CNY	11.88%
2014 Q2	320.82 Million CNY	-8.62%
2013 Q2	354.07 Million CNY	100.85%
2013 Q4	351.08 Million CNY	-0.84%
2013 FY	705.15 Million CNY	0.0%
2012 Q4	176.28 Million CNY	0.0%

Peer Revenue Comparison of Austar Lifesciences Limited

Name	Revenue	Revenue Difference
Vincent Medical Holdings Limited	717.97 Million HKD	-145.655%